Ligand Pharma (LGND) Misses Q4 EPS by 45c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq set for higher open as oil prices extend declines, midterm results awaited
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 307.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $307.02 | 52 Week High | $139.79 | |||
| Open | $307.02 | 52 Week Low | $82.07 | |||
| Day High | $307.02 | P/E | 714.00 | |||
| Day Low | $307.02 | EPS | $0.43 | |||
| Volume | 302 | |||||
